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Molecular dynamicsThis review discusses the application of cellular biology, molecular biophysics, and computational simulation
to understand membrane-mediated mechanisms by which oxysterols regulate cholesterol homeostasis. Side-
chain oxysterols, which are produced enzymatically in vivo, are physiological regulators of cholesterol
homeostasis and primarily serve as cellular signals for excess cholesterol. These oxysterols regulate
cholesterol homeostasis through both transcriptional and non-transcriptional pathways; however, many
molecular details of their interactions in these pathways are still not well understood. Cholesterol trafﬁcking
provides onemechanism for regulation. The current model of cholesterol trafﬁcking regulation is based on the
existence of two distinct cholesterol pools in the membrane: a low and a high availability/activity pool. It is
proposed that the low availability/activity pool of cholesterol is integrated into tightly packing phospholipids
and relatively inaccessible to water or cellular proteins, while the high availability cholesterol pool is more
mobile in the membrane and is present in membranes where the phospholipids are not as compressed.
Recent results suggest that oxysterols may promote cholesterol egress from membranes by shifting
cholesterol from the low to the high activity pools. Furthermore, molecular simulations suggest a potential
mechanism for oxysterol “activation” of cholesterol through its displacement in the membrane. This review
discusses these results as well as several other important interactions between oxysterols and cholesterol in
cellular and model lipid membranes. This article is part of a Special Issue entitled: Membrane protein
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Membranes are an essential component of cells, serving to
partition the inside of the cell from its extracellular environment as
well as compartmentalizing different organelles within the cell. The
structures of biological membranes are derived primarily from their
constituent phospholipids attached to a glycerol backbone. Phospho-
lipids are a diverse group, but all retain a polar or charged headgroup
and one or more long hydrophobic tails. This basic structure provides
an amphiphilic character that allows self-assembly into stable
membrane bilayers.
Membranes not only serve to separate cellular compartments but
also to regulate cellular behavior, often through protein-membrane
interactions [1]. Membrane inﬂuence on protein function has been
described for many proteins; e.g., the ﬂuidity and cholesterol
composition of the membrane environment regulates the activity of
adenylate cyclase [2], membrane structure regulates G-protein
activity [3], and phospholipid chain length alters the behavior of
diacylglycerol kinase through hydrophobic matching of the mem-
brane to the protein [1]. Membrane structure is also known to govern
protein sorting and association. Reversible protein association with
membranes to form enzymatically active complexes is controlled in
part through the composition and structure of membranes [4].
Integral membrane protein distribution within the cell is regulated
by hydrophobic matching of the protein to membranes of different
thicknesses [5].
Membrane lipids themselves also serve as signaling molecules:
phosphatidylinositols function as messengers in a number of
membrane-cytoskeletal interactions [6], and sphingolipids signal in
apoptosis, the cell cycle, and differentiation [7,8]. More common lipids
also signal through movement and trafﬁcking. For example, move-
ment of phosphaditylserine marks apoptotic cells [9] and cholesterol
depletion alters protein localization and trafﬁcking [10,11].
Phospholipids are responsible for forming the basic structure of
biomembranes, but sterols, while not necessary for eukaryotic
membrane structure, modulate membrane structure and are essential
for membrane function. All sterols are built around four rings fused in
a trans conﬁguration, which provide a rigid, planar, and hydrophobic
structure. Decoration of this base steroid ring structure with different
functional groups accounts for the diversity among sterol species. In
contrast to the wide variety of phospholipid species found in
biological membranes, most membranes contain only a single
dominant sterol. Cholesterol is the primary sterol found in mamma-
lian cells, and it is required for mammalian cell function and viability.
While cholesterol is largely hydrophobic, its hydroxyl group confers
an essential amphiphilic character that allows it to readily incorporate
into phospholipid bilayers, extensivelymodulating their structure and
behavior.
Cholesterol primarily serves as a structural component of cellular
membranes. When incorporated into phospholipid bilayers, choles-
terol aligns so that its polar hydroxyl group is near the interface with
the aqueous environment while its hydrophobic body is buried in the
bilayer [12,13]. The interaction of cholesterol with neighboring
phospholipids alters membrane structure. The alignment and order-
ing of nearby phospholipid tails cause membrane condensation,
decreasing the area of the membrane and increasing the thickness
[13]. Cholesterol also broadens the liquid-to-solid phase transition,
inducing an intermediate liquid-ordered phase that retains lateral
mobility while increasing lipid order [14–16]. These changes result in
a mechanically stronger membrane with decreased permeability due
to tighter packing among lipids [10,14].
Because cholesterol is such an important part of mammalian
membranes, cells expend signiﬁcant amounts of energy to control
their cholesterol levels through a variety of mechanisms including de
novo synthesis, intracellular transfer and storage of cholesterol, and
elimination of cholesterol through efﬂux and metabolic pathways[17,18]. Orchestration of these cholesterol homeostatic pathways is
accomplished through a variety of mechanisms. Oxygenated de-
rivatives of cholesterol (see Fig. 1) are produced by either the attack of
cholesterol by reactive oxygen species (e.g., 7-ketocholesterol, 7α-
hydroxycholesterol, and 7β-hydroxycholesterol) or by enzymatic
reactions (e.g., 24(S)-hydroxycholesterol, 25-hydroxycholesterol, and
27-hydroxycholesterol) and play a central role in regulation of
cholesterol homeostatic pathways. This review focuses on the
importance of oxysterols in understanding cholesterol homeostasis,
discusses the role of membranes themselves in oxysterol signaling,
and demonstrates how techniques that provide different scales of
resolution can improve our understanding of the molecular basis of
cellular cholesterol homeostasis.
2. The role of oxysterols in cholesterol homeostasis
The side-chain oxysterols, such as 24-, 25-, and 27-hydroxycho-
lesterol (HC; see Fig. 1) are produced enzymatically in vivo and are
physiologic regulators of cholesterol homeostasis. These oxysterols
principally serve as signals for excess cholesterol in the cell. When
cholesterol is in excess, some of that cholesterol is oxygenated by
endogenous hydroxylases [19,20]. Inhibition of oxysterol production
through either direct disruption of hydroxylases [21] or disruption of
cholesterol trafﬁcking to the hydroxylases [22] interferes with the
ability of cells to appropriately respond to elevated levels of
cholesterol, indicating that the feedback effects of cholesterol on
regulatory pathways are mediated in part through cholesterol
conversion into side-chain oxysterols.
2.1. Pathways of homeostasis
Oxysterols regulate cholesterol homeostasis through transcrip-
tional and non-transcriptional mechanisms (see Fig. 2), both of which
are necessary for tight control of cellular cholesterol levels. Tran-
scriptional regulation allows the cell to efﬁciently respond to changes
in ambient cholesterol concentration by altering the production of
new proteins. Modulation of protein levels, however, occurs over a
relatively slow timescale (e.g. hours). By contrast, non-transcriptional
regulation, which can directly modify the behavior of proteins, allows
for a cellular response to changes in cholesterol concentration over a
faster time scale (e.g. minutes).
Two major pathways have been described in which oxysterols are
known to play a role as transcriptional regulators. Side-chain
oxysterols are the physiological ligands of the liver X receptors
(LXRs) [23,24]. LXRs up-regulate the expression of a number of genes
involved in export of excess cholesterol from the cell, including bile
acid synthesis proteins such as Cyp7A1 [25], and the ABCA1
transporter which transfers excess cholesterol to circulating apolipo-
proteins [26]. Side-chain oxysterols also serve to suppress the
maturation of the sterol response element binding-protein (SREBP)
family of transcription factors [27,28]. Activated SREBPs up-regulate
the expression of genes involved in cholesterol synthesis and uptake,
including HMGCoA reductase, the rate-limiting enzyme in the
cholesterol synthesis pathway, and the LDL receptor, which mediates
the uptake of cholesterol-rich LDL [17,29–33]. In response to elevated
cholesterol concentrations, oxysterols are produced that suppress the
transcription of genes responsible for cholesterol synthesis and
uptake while up-regulating the transcription of genes involved in
cholesterol export.
Oxysterols can also affect rapid changes in cholesterol levels
through post-transcriptional mechanisms. In response to cholesterol
loading, cholesterol is rapidly converted to oxysterols, which promote
the ubiquitination of HMGCoA reductase and targets it for protea-
some-dependent degradation [21,30,34,35]. Oxysterols also regulate
cholesterol trafﬁcking between the plasma membrane and internal
compartments, most importantly the endoplasmic reticulum (ER)
Fig. 1. An overview of common biological oxysterols, both those produced from attack on cholesterol by reactive oxygen species (7-keto-, 7α-hydroxy-, and 7β-hydroxycholesterol)
and those produced enzymatically by the cell (25(S)-hydroxy-, 25-hydroxy-, and 27-hydroxycholesterol).
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modulation of this trafﬁcking affects the cell's response to changes in
total cholesterol levels. In particular, acyl-CoA cholesterol acyl
transferase (ACAT) conjugates excess ER cholesterol with fatty acids
to produce cholesteryl esters that are stored in lipid droplets [37].
ACAT-dependent cholesterol esteriﬁcation is largely controlled by the
ER cholesterol concentration. Thus, oxysterols, which stimulate
transfer of cholesterol from the plasma membrane to the ER,
indirectly promote cholesterol esteriﬁcation by ACAT [36,37]. These
effects occur on a much faster time scale than oxysterol-dependentFig. 2. Pathways of cholesterol homeostasis.transcriptional regulation through the SREBP and LXR pathways,
allowing the cell to quickly shut down cholesterol synthesis and
shuttle excess cholesterol to storage compartments.
2.2. Mechanisms of homeostasis
While oxysterols are known to act in these pathways, in many
cases, the mechanisms through which they act are less well
understood. The most straightforward mechanism of action for
oxysterols is activation of the LXR pathway. Side-chain oxysterols
were identiﬁed as activators of LXRs at physiological concentrations
[24]. Activation requires an intact LXR ligand binding domain, and co-
incubation of LXR with oxysterol partially protects LXR from
proteolytic digestion. Furthermore, activation is oxysterol speciﬁc,
with minor structural or stereochemical changes causing large
differences in activation [24,38]. This suggests a simple model
where oxysterols bind speciﬁcally and directly to LXR as ligands,
causing conformational changes which result in activation.
Side-chain oxysterol suppression of SREBP activation appears to be
more complex [17,29]. When ﬁrst synthesized, SREBPs are inactive;
they must undergo proteolytic maturation to become active tran-
scription factors. This activation occurs through transport of SREBPs
from the ER to the Golgi complex where Golgi-resident proteases
subsequently cleave it to produce an active fragment. Transport is
facilitated by the SREBP cleavage-activating protein (Scap), which
binds to the SREBP regulatory domain to form an SREBP-Scap
complex. Scap also contains a sterol sensing domain (SSD), which
causes conformational changes in Scap in the presence of cholesterol.
When ER cholesterol levels are low, Scap binds to vesicular packaging
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cholesterol-rich conditions, Scap instead binds to the ER-resident
Insig proteins, blocking vesicular transport and SREBP maturation
[33].
While cholesterol itself can suppress SREBP activation, side-chain
oxysterols are signiﬁcantly more potent [27,28]. Cholesterol directly
binds to the Scap SSDs, causing a conformational change that induces
binding to Insig [33]. Oxysterols also induce Scap/Insig binding, but do
not bind Scap [39]. They do, however, interact with Insig, as measured
through competitive binding experiments [39]. We have observed
that the effects of oxysterols on SREBP suppression are not
stereospeciﬁc; enantiomeric oxysterols suppress SREBP activation as
effectively as natural oxysterols [38]. We propose that the oxysterols
do not exert their effects through direct oxysterol-protein interactions
but rather via a non-stereospeciﬁc mechanism.While this mechanism
has not yet been conclusively identiﬁed, oxysterols are known to
perturb the behavior of membranes, making oxysterol/membrane
interactions a promising candidate.
Regulated degradation of HMGCoA reductase acts through a
remarkably similar mechanism. Like Scap, HMGCoA reductase
contains a SSD that induces conformational changes in the presence
of cholesterol [30,35]. This exposes ubiquitination sites which, once
ubiquitinated, target it to the proteasome where it is degraded
[30,35]. The proteolytic inactivation of HMGCoA reductase is
dependent on the production of oxysterols [21]. Additionally,
ubiquitinase recruitment is dependent on binding of HMGCoA
reductase to Insig, the same regulatory protein involved in SREBP
regulation [40]. This suggests that oxysterols may act similarly in both
pathways through non-stereospeciﬁc modulation of Insig interactions
with other proteins.
Oxysterol regulation of cholesterol trafﬁcking is even less well
understood. Membrane and soluble protein carriers for cholesterol
movement within the cell are required to explain the regulation and
homeostasis of cholesterol. However, individual pathways, driving
forces, and regulatory elements are not known for cholesterol
trafﬁcking between the plasma membrane and the ER. Cholesterol
movement between the two compartments is modulated by oxyster-
ols on a timescale of minutes, suggesting that it is assisted by some
active process rather than passively diffusing [41,42]. If additional
cholesterol is directly removed from or added to the plasma
membrane, the ER cholesterol concentration responds extremely
rapidly. In particular, increases in the plasma membrane cholesterol
concentration quickly result in much larger increases in the ER
cholesterol concentration: an increase of 20% in the plasma
membrane can result in as much as a ﬁve-fold increase in ER
cholesterol content. This non-linear response suggests an alteration of
both transport kinetics and compartment capacity in the regulation of
cholesterol subcellular distributions.
The current model of how this trafﬁcking is regulated is based on
the hypothesis that there exist two distinct cholesterol pools in the
membrane: a low and a high activity pool [41,42]. It is proposed that
the low activity pool consists of cholesterol that is sequestered within
the phospholipids and relatively inaccessible to other molecules,
while the high activity pool of cholesterol that is more accessible and
mobile in the non-condensed phospholipids of the membrane.
Distribution between the high and low activity pools is determined
by the ability of the phospholipids to condense with cholesterol,
which in turn is dependent on the phospholipid composition of the
membrane. Thus, raising the plasma membrane cholesterol concen-
tration can saturate the ability of the membrane to accommodate
cholesterol in the condensed phospholipids, whereupon excess
cholesterol transitions into the high activity pool where it is more
available for trafﬁcking to the ER. Measurements of cholesterol
availability to external sources such as cholesterol oxidase, cyclodex-
trin, and perfringolysin O show increases in cholesterol availability
that correspond with ER trafﬁcking measurements [42,43].This model suggests that oxysterols drive cholesterol trafﬁcking by
shifting cholesterol from the low to the high activity pools. The
cholesterol availability model may also explain the oxysterol effects
on SREBP suppression and HMGCoA reductase degradation. Suppres-
sion of SREBP activation and an increase in availability of ER
cholesterol to perfringolysin O occurs very abruptly at the same
cholesterol concentration, indicating that cholesterol availability may
be directly related to signaling in these pathways [43].
3. Oxysterol behavior in model membranes
Cellular models provide a physiologically relevant, intact environ-
ment for study of cholesterol homeostasis. While these models allow
for the study of complex interactions between pathways required for
a complete understanding of cholesterol homeostasis, they can also
interfere with a detailed stepwise understanding of individual
pathways. To resolve this issue, simpler models are used which
mimic relevant parts of the complex system. Cellular studies have
suggested that some of the effects of oxysterols on biological
pathways may be mediated through oxysterol perturbation of
membrane properties and oxysterol activation of cholesterol within
the membrane. Experiments using liposomes and membrane mono-
layers allow direct investigation of oxysterol effects on membranes
and membrane components without interference from protein
components present in a cell.
Liposome experiments have been performed using a carboxy-
ﬂuorescein (CF) assay originally developed for investigation of pore-
forming molecules. Liposomes prepared with a concentration of CF
high enough to cause self-quenching were incubated with oxysterols.
When treated with a pore-forming molecule like melittin, the pores
formed in the liposomes allow CF to leak out, lowering the
concentration in the liposomes below that necessary for self-
quenching, and producing a ﬂuorescent signal. This “dequenching”
signal was observed upon treatment with oxysterols including 25-HC
and 27-HC [38]. Side-chain oxysterols are known to increase
membrane permeability to ions and small polar molecules, suggesting
that oxysterols might be permeabilizing the membrane, allowing CF
to leak out [44,45]. This hypothesis was tested by ﬁrst treating
liposomes with oxysterols and subsequently treating them with
cyclodextrin to remove the added oxysterol from the liposomes. It
was found that the cyclodextrin treatment fully reversed the
dequenching caused by the oxysterols themselves [38]. The revers-
ibility of the signal rules out the possibility that CF is simply leaking
out of the liposomes due to pore formation. Rather, the addition of
oxysterols likely induces membrane expansion, increasing liposome
volume and dilution of the CF, whereas removal of the oxysterols
reversed the expansion and led to requenching of the CF.
However, these assays provide indirect evidence for membrane
expansion. More direct evidence for oxysterol effects on membranes
comes from Langmuir ﬁlm balance experiments on oxysterol/phospho-
lipidmonolayers. Suchmodelmembrane systems have beenwidely used
to study the effects of cholesterol and cholesterol derivatives on
monolayer behavior, and recently several groups have extended these
experiments to oxysterol interactions. With cholesterol and most
cholesterol derivatives, as the mole fraction of the sterol in the
phospholipid monolayer increases, the mean molecular area decreases
in a non-linear fashion [38,46,47]. The reduction in mean molecular area
as compared to what would be expected from a mixture of two non-
interacting components, indicates that these sterols condense mem-
branes. In contrast, oxysterols increase the mean molecular area as
compared with an ideal mixture. These effects are highly dependent on
the phospholipid composition of the membrane. Cholesterol's condens-
ing effects are stronger inmembranes containing saturated lipids such as
dipalmitoylphosphatidylcholine (DPPC), while the side-chain oxysterols
show larger expansive effects in membranes containing unsaturated
lipids such as dioleolyphosphatidylcholine (DOPC) and 1-palmitoyl-2-
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side-chain oxysterols has been shown to be non-enantioselective, as
oxysterol enantiomershave identical effects as their natural counterparts.
4. Molecular simulations of oxysterol-membrane interactions
Cellular studies have demonstrated that side-chain oxysterols
inﬂuence cholesterol accessibility in membranes and biophysical exper-
iments have shown that they change membrane structure. However,
these experiments cannot provide themolecular details of howoxysterols
cause these effects. In order to obtain atomic scale resolution, computa-
tional models can be used to simulate small systems. The large-scale
changes in these simulated systems can be directly compared with
experimental data to provide insight into themolecular details which are
only available from the simulations. Membrane simulations have been
performed for decades, but the increasing speed and power of the
available computational resources have allowed simulations to become
larger and more complex. While cholesterol/phospholipid membrane
simulations have been performed by multiple laboratories over the last
ﬁfteen years, oxysterols/phospholipid membranes have only recently
begun to be simulated. Recently, our group published results from
simulations of membranes containing various concentrations of choles-
terol, 25-HC, and POPC, a simple phospholipid [12,48]. Simulations of
POPC alone, POPC with low (18%) and high (30%) concentrations of
cholesterol or 25-HC, and POPC with low concentrations (15%) of both
cholesterol and 25-HC were performed.
4.1. Testing simulations against experimental observations
Because simulations are necessarily imperfect models of real-world
systems, beforemolecular and structural conclusions canbedrawn from
the simulation, mesoscopic system properties must ﬁrst be compared
with experimental data. The ﬁrst andmost straightforward comparison
is between experimental and simulation membrane area measure-
ments. Reasonable agreement between mean molecular area for
simulated and experimental pure phospholipid bilayers was demon-
strated [12,48]. While direct comparisons between areas for sterol-
containing bilayers could not be made, general agreement between
simulated bilayers and experimental monolayers was found for the
effects of cholesterol and 25-HC on membrane area. In particular,
cholesterol was found to have a generally condensing effect that was
stronger at low concentrations, while 25-HC had an expansive effect
thatwas roughly linear up to 30 mol% [12,48]. Partitioningofmembrane
area using solvent-accessible surface area showed that most of the
changes in membrane area were due to changes in phospholipid area
induced by the cholesterol or 25-HC present in the membrane [12].
Mass density proﬁles for the simulations were also performed,
allowing estimation of changes in membrane thickness. As demon-
strated experimentally, cholesterol thickens the bilayer, increasing
the distance between the two phosphate peaks [12,48]. 25-HC has the
opposite effect, thinning the bilayer [12,48]. Volume measurements,
calculated as the product of the membrane area and thickness, show
that the marginal volumes of cholesterol and 25-HC membranes are
roughly similar, indicating that changes in area are compensated by
changes in thickness [48].
4.2. Molecular details of membrane-oxysterol interactions
The tail order of membrane phospholipids is used as a reporter of
membrane organization and accessible in both experimental NMR
measurements and molecular simulation. As has been shown
experimentally, the addition of cholesterol causes dose-dependent
increases in lipid tail order along the length of the chain, which can be
attributed to tail packing around the rigid cholesterol rings [48]. The
effects of 25-HC are very different, with increases in tail order near the
lipid head group and decreases in order near the ends of the tails,consistent with experimental results indicating a loss of membrane
compression due to disordering of the lipid tails by the oxysterols.
The increase in cholesterol availability to external acceptors seen
in oxysterol-containing membranes suggests structural changes in
cholesterol interactions with phospholipids induced by oxysterols.
The simulations containing both cholesterol and 25-HC were
examined for any structural changes in phospholipids or cholesterol
that could be indicative of increased cholesterol accessibility. It was
found that the average position of cholesterol within the membrane
was shifted slightly into the aqueous phase in the presence of 25-HC
[12]. This was not merely an effect of a higher total sterol
concentration because higher cholesterol concentrations did not
show the same shift. This shift in cholesterol position was accompa-
nied by an increase in cholesterol exposure to water and an increase in
hydrogen bonding between cholesterol hydroxyl groups and water.
Thus oxysterols appear to alter cholesterol accessibility by allowing it
to protrude more from the membrane.
The effects of oxysterols on membrane order and cholesterol
accessibility may be attributable to the orientation and position of
sterols in the bilayer (see Fig. 3). Cholesterol adopts primarily parallel
orientations under all conditions, with the long axis of the sterol rings
roughly orientedwith themembrane normal [12,48]. 25-HC shows two
preferred orientations: a parallel orientation like that of cholesterol, and
an interfacial orientation with the ring axis tilted and the sterol tail
angled towards thebilayer surface, allowingbothhydroxyl groupsof the
molecule to interact with both water and neighboring phospholipid
headgroups [12,48]. Each of these oxysterol orientations may be
relevant to their effects. The parallel orientations result in burial of the
25-hydroxyl group. These buried polar groups self-associate in the
generally hydrophobic bilayer interior and produce a cross-leaﬂet
network of hydrogen bonded oxysterols that could contribute to
membrane thinning. The interfacial orientations similarly connect
neighboring phospholipids with hydrogen bonds and could directly
interfere with cholesterol-phospholipid interactions.
5. Conclusions
The biological importance of oxysterols in the regulation of
cholesterol homeostasis has become increasingly well established.
Oxysterols, in particular the side-chain oxysterols, have been identiﬁed
as physiological effectors in LXR activation and SREBP activation.
Furthermore, they are known to have effects on HMGCoA reductase
degradation and cholesterol trafﬁcking. The precise mechanisms
through which they act, however, have yet to be fully elucidated.
When investigating how oxysterols can perturb cholesterol homeo-
stasis, multiple scales of analysis are useful. Cells provide the most
complete environment for experimentation, where oxysterol effects on
speciﬁc pathways can be conclusively demonstrated under physiolog-
ical conditions. However, while these experiments can provide clues to
how these effects are produced, it is difﬁcult to obtain clear evidence for
mechanisms at the cellular level. Biochemical and biophysical studies
using simple membranes and puriﬁed proteins allow experimentation
and testing of potential mechanisms at the expense of potentially
limiting applicability to the intact system. Meanwhile, well-validated
molecular simulations provide detailed structural information on very
limited systems. Because each of these types of studies provides distinct
types of information on oxysterol effects, their combined use has
provided a fuller understanding of oxysterol effects on cholesterol
disposition in bilayer membranes.
Based on the more comprehensive understanding derived from
these complementary studies, oxysterol effects on membranes and
membrane lipids have been identiﬁed as a likely molecular basis for
oxysterol signaling. Two membrane effects of side-chain oxysterols
provide potential mechanisms of action: oxysterol perturbation of
gross membrane properties, and oxysterol activation of cholesterol.
Side-chain oxysterols have been found to change membrane
Fig. 3. Differences in the preferred orientations of cholesterol (yellow) and 25-HC (green) can clearly be seen, with cholesterol preferring upright and 25-HC tilted orientations. The
increased exposure of sterols in the mixed bilayer can be seen as sterols shift into the phospholipid headgroup (blue and ochre) region.
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membrane expansion, thin the bilayer signiﬁcantly, and increase
membrane permeability. These kinds of structural changes can
inﬂuence protein behavior: thickness differences between cellular
membranes are thought to help sort membrane proteins to their
appropriate location [5] and membrane structural changes can alter
signaling and behavior in proteins such as adenylate cyclase, G-
proteins, diacylglycerol kinase, and others [1–4,49].
The activation of cholesterol by side-chain oxysterols has been
identiﬁed in cellular systems by measuring cholesterol availability to
cholesterol oxidase attack. Structural changes in cholesterol/membrane
interactionshave alsobeen seen in simulatedmembranes that appear to
be indicative of cholesterol activation. Trafﬁcking of plasma membrane
cholesterol to the ER is dependent on the membrane cholesterol
concentration, with higher concentrations shifting cholesterol into the
active pool that is rapidly transferred to internal compartments. This
implies that the sharp increase in the ER cholesterol pool upon addition
of 25-HC reﬂects its ability to increase the availability of cholesterol. A
similarmechanismmay be important for regulation of SREBP activation
andHMGCoARdegradation. Oxysterol activation of cholesterol in the ER
membrane could free cholesterol to bind to and activate the sterol
sensing domains of these regulatory proteins.
A potential limitation of this model for oxysterol signaling is that, in
cells, the bulk concentrations of oxysterols are orders ofmagnitude lower
that what is used in the oxysterol simulations or the oxysterol cellular
experiments. If those membrane effects are concentration dependent,
then this lowered concentration would seem to rule out membranes as
physiological effectors, though theymay still be relevantwhen oxysterols
are added to membranes in large amounts. On the other hand, while the
bulk concentrations of oxysterols are extremely low, the localization of
oxysterols within the cell remains to be determined. It is possible that
oxysterolsmay concentrate in speciﬁc cellular compartments,where they
could exert regulatory effects. Furthermore, it is unclear whether the
membrane effects, in particular cholesterol activation, are stronglyconcentration dependent. If oxysterols essentially act as catalysts for
cholesterol transfer from a complexed to an active pool, then depletion of
that active pool by transfer out of the membrane or through binding to a
sensing protein would allow that pool to be replenished by further
oxysterol-induced cholesterol activation.
Further work is necessary to fully understand the mechanisms of
oxysterol action in the many cholesterol homeostatic pathways in
which it is involved. The lipid dependence of oxysterol effects is not
clear. It is known that ER and plasmamembranes have different active
cholesterol thresholds, but any distinctions in how oxysterols affect
them are not yet known. Both direct examination using isolated
membranes and simulations of oxysterols with different lipid
composition could provide further insight.
While membrane simulations have been well validated, NMR
spectroscopy of liposomes or bicelles could provide further structural
evidence for oxysterol-induced cholesterol activation. The structural
details of the complexed and active pools of cholesterol are also still
unclear. Simulations of membranes with higher cholesterol concen-
trations should allow both pools to be clearly observed. Finally, other
sterols are also of interest. Most work to date has been done with 25-
HC, but 27-HC is known to have slightly different effects, and the
structural reasons are not known. Also of interest is LY295427, a
sterol-derived molecule that inhibits the regulatory effects of side-
chain oxysterols by an unknown mechanism. Analysis of the behavior
of these sterol compounds in model membranes and dynamic
simulations may provide further insight into the molecular mecha-
nisms by which oxysterols exert their physiological effects.Acknowledgements
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